CONMED Pre-Tax Income 2010-2024 | CNMD

CONMED pre-tax income from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
CONMED Annual Pre-Tax Income
(Millions of US $)
2023 $81
2022 $-71
2021 $73
2020 $2
2019 $31
2018 $51
2017 $29
2016 $19
2015 $45
2014 $47
2013 $51
2012 $59
2011 $-2
2010 $46
2009 $18
CONMED Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $56
2024-06-30 $38
2024-03-31 $25
2023-12-31 $41
2023-09-30 $20
2023-06-30 $17
2023-03-31 $2
2022-12-31 $-11
2022-09-30 $16
2022-06-30 $-93
2022-03-31 $17
2021-12-31 $30
2021-09-30 $17
2021-06-30 $16
2021-03-31 $10
2020-12-31 $13
2020-09-30 $17
2020-06-30 $-33
2020-03-31 $3
2019-12-31 $17
2019-09-30 $9
2019-06-30 $6
2019-03-31 $-2
2018-12-31 $20
2018-09-30 $6
2018-06-30 $12
2018-03-31 $12
2017-12-31 $18
2017-09-30 $9
2017-06-30 $8
2017-03-31 $-7
2016-12-31 $9
2016-09-30 $10
2016-06-30 $4
2016-03-31 $-3
2015-12-31 $11
2015-09-30 $13
2015-06-30 $11
2015-03-31 $9
2014-12-31 $16
2014-09-30 $1
2014-06-30 $14
2014-03-31 $16
2013-12-31 $15
2013-09-30 $7
2013-06-30 $14
2013-03-31 $14
2012-12-31 $16
2012-09-30 $13
2012-06-30 $16
2012-03-31 $16
2011-12-31 $-44
2011-09-30 $13
2011-06-30 $14
2011-03-31 $14
2010-12-31 $11
2010-09-30 $12
2010-06-30 $12
2010-03-31 $11
2009-12-31 $8
2009-09-30 $2
2009-06-30 $2
2009-03-31 $6
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.216B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36